Alembic Pharmaceuticals
APLLTD.NS
#3979
Rank
โ‚น202.35 B
Marketcap
โ‚น1,029
Share price
-0.92%
Change (1 day)
41.62%
Change (1 year)

Revenue for Alembic Pharmaceuticals (APLLTD.NS)

Revenue in 2024 (TTM): โ‚น61.87 Billion

According to Alembic Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น62.68 Billion. In 2023 the company made a revenue of โ‚น59.65 Billion an increase over the revenue in the year 2022 that were of โ‚น55.87 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alembic Pharmaceuticals from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น61.87 B3.73%
2023 โ‚น59.65 B6.75%
2022 โ‚น55.87 B10.57%
2021 โ‚น50.53 B-2.93%
2020 โ‚น52.05 B24.01%
2019 โ‚น41.97 B8.72%
2018 โ‚น38.61 B27.9%
2017 โ‚น30.18 B0.22%
2016 โ‚น30.12 B1.54%
2015 โ‚น29.66 B50.15%
2014 โ‚น19.75 B13.14%
2013 โ‚น17.46 B